Selective Screening Before Immunosuppressive Therapy Improves Response Rates … – The MDS Beacon
Selective Screening Before Immunosuppressive Therapy Improves Response Rates ... The MDS Beacon Most patients in the study received treatment with cyclosporine (Sandimmune); six patients received treatment first with anti-thymocyte globulin (ATG), followed by cyclosporine. These drugs target and reduce the number of circulating T cells. ... |
Quick Sequential Regimen Shows Promise As Preparative Therapy Prior To Stem … – The MDS Beacon
Quick Sequential Regimen Shows Promise As Preparative Therapy Prior To Stem ... The MDS Beacon In addition, most of the 30 patients in the study received anti-thymocyte globulin (ATG) for several days between induction and conditioning therapy to help prevent graft-versus-host-disease. Patients received their transplants within a median of 134 ... |
Stem Cell Transplantation With Reduced-Intensity Preparative Therapy And … – The MDS Beacon
Stem Cell Transplantation With Reduced-Intensity Preparative Therapy And ... The MDS Beacon ... stem cell transplants with partially mismatched donors were successful in patients with MDS and acute myeloid leukemia after reduced-intensity preparative therapy with busulfan (Busulfex), fludarabine (Fludara), and anti-thymocyte globulin (ATG). ... |